Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Oric Pharmaceuticals, Inc. (ORIC)
Market Open
26 Oct, 07:31 PM
NASDAQ (NGS)
All
(5)
DE
(4)
US
(1)
NASDAQ (NGS)
Primary
XDUS
XFRA
XMUN
XSTU
$
9.
04
-4.13
-31.3971%
$
1.43B
Market Cap
-
P/E Ratio
-
Div Yield
5.3M
Volume
-1.99
Eps
$
13.17
Previous Close
Investors:
BG
KM
MM
+22
Analysts:
Watching
Watch
Add Transaction
Day Range
8.91
13.23
Year Range
7.23
14.68
Want to track
ORIC
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Statistics
News
Historical Data
Investors
Analysts
Oric Pharmaceuticals, Inc. (ORIC) Statistics
Valuation metrics
Market Cap
1.43B
Enterprise value
1.33B
Trailing P/E (ttm)
-9.76
Forward P/E
-5.35
PEG ratio
-0.27
Price/Sales (ttm)
-
Price/Book (mrq)
3.73
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
-9.31
Overview
Shares outstanding
103.49M
Float
82.53M
Shares short
22.01M
% Held by insiders
0.06%
% Held by institutions
1.14%
Average volume (10 days)
1.43M
Average volume (90 days)
1.45M
Price summary
52-Week low
7.23
52-Week high
14.68
Beta
1.1
50-Day moving average
12.67
200-Day moving average
11.04
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-
Operating margin
-
Operational effectiveness
Return on assets
-0.35%
Return on equity
-0.35%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
-
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-148.72M
Net income to common (ttm)
-135.21M
Diluted EPS (ttm)
-1.3
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
281.93M
Total cash per share (mrq)
2.45
Total debt (mrq)
6.73M
Total Debt/Equity (mrq)
0.01
Current ratio (mrq)
13.19%
Book value per share (mrq)
3.53
Cash Flow
Cash flow statement
-110.88M
Levered free cash flow (LFCF)
-67.97M